University of Illinois at Chicago
Announcement of an Exempt Purchase
Vendor: Fisher Clinical Services Inc.,
Change Order Amount: $80,000
After initial submission of contract for review, negotiation, revised completion date and changes in personnel for the vendor and user department lengthen the negotiation process significantly which resulted in an increase of 15%. In addition, the research has now been funded for 6 years instead of the initial 5 years.
The State Purchasing Officer for this procurement is now Lee Saulter.
The University award process may be delayed up to thirty days as this award goes through a state approval process.
Fisher Clinical Services Inc.,Mount Prospect, IL
- Amount: An estimated $570,000
- Terms: An estimated start date of 1/1/2022 through 12/31/2027
- Renewals: None
Summary
Vendors
1 total
0 BEP vendors
0 VBP vendors
0 Small businesses
The University award process may be delayed up to thirty days as this award goes through a state approval process.
First published Thursday, November 11, 2021
The University awarded a contract for packaging, labeling, inventory management.
Fisher Clinical Services will provide packaging, labeling, inventory management, distribution and transportation of investigational products to the two research sites in this study. Vendor will provide secondary labeling and kitting service of two investigational products used in the study. Sites will be resupplied with investigational products on demand. Direct-to-site shipments will be sent via cold-chain.
This purchase is exempt from the usual selection processes of the Procurement Code because the procurement expenditure is for performing sponsored research and other sponsored activities under grants and contracts funded by the sponsor or by sources other than State appropriations. (30 ILCS 500 / 1-13(b)(8)) Fisher clinical service is a subsidiary of ThermoFisher Scientific, it has the resources to manage this investigative project. Due to the volume and logistics our own facilities cannot handle the investigative drug volumes required by the sponsor. UIC is the lead site of an investigator initiated study on multiple myeloma. The other research site of this 2-site study is Emory University. The principal investigator delegated the Investigational Drug Service (IDS) to manage and distribute investigational products under cold-chain in compliant with Good Clinical Practice guidelines. This single arm multi-site study is anticipated to treat 50 participants with an enrollment period of 36 months plus a treatment period of up to 36 months. IDS does not have the space, personnel, time and expertise to meet the scope of managing and distributing investigational products outside our clinic area.
For instructions on how to obtain a comprehensive purchase description, disclosure or contract forms, contact:
The State of Illinois has a policy to encourage prospective vendors to hire
qualified veterans, minorities, females, persons with disabilities and ex-offenders.